Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3619335 | 0.90 | TAAR1 (0.62) | TAAR1 | |
| SCHEMBL3619338 | 0.90 | TAAR1 (0.62) | TAAR1 | |
| SCHEMBL3622246 | 0.89 | TAAR1 (0.51) | TAAR1 | |
| SCHEMBL3622251 | 0.89 | TAAR1 (0.51) | TAAR1 | |
| SCHEMBL3621037 | 0.83 | TAAR1 (0.68) | TAAR1 | |
| SCHEMBL3621041 | 0.83 | TAAR1 (0.68) | TAAR1 | |
| SCHEMBL3620936 | 0.81 | TAAR1 (0.49) | TAAR1 | |
| SCHEMBL3620940 | 0.81 | TAAR1 (0.49) | TAAR1 | |
| SCHEMBL3621916 | 0.81 | TAAR1 (0.59) | TAAR1 | |
| SCHEMBL20462498 | 0.81 | TAAR1 (0.41) | TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10632105-B2 | Pharmacological stimulation to facilitate and restore standing and walking functions in spinal cord motor disorders | ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL) (CH) | 2020-04-28 | — | — | US | disclosed |
| US-20190022371-A1 | ELECTRODE ARRAY FOR TRANSCUTANEOUS ELECTRICAL STIMULATION OF THE SPINAL CORD AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2019-01-24 | — | — | US | disclosed |
| US-20180221651-A1 | METHODS OF FABRICATING AN ELECTRODE ARRAY FOR TRANSCUTANEOUS ELECTRICAL STIMULATION OF THE SPINAL CORD | UNIV CALIFORNIA (US) | 2018-08-09 | — | — | US | disclosed |
| US-20160158204-A1 | PHARMACOLOGICAL STIMULATION TO FACILITATE AND RESTORE STANDING AND WALKING FUNCTIONS IN SPINAL CORD MOTOR DISORDERS | ONWARD MEDICAL N.V. (NL) | 2016-06-09 | — | — | US | disclosed |
| US-20160158204-A1 | PHARMACOLOGICAL STIMULATION TO FACILITATE AND RESTORE STANDING AND WALKING FUNCTIONS IN SPINAL CORD MOTOR DISORDERS | ONWARD MEDICAL N.V. (NL) | 2016-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10632105-B2 | Pharmacological stimulation to facilitate and restore standing and walking functions in spinal cord motor disorders | ADRA2C, ADRA2A, ADRB2 | TAAR1 235/4885 |
| US-20160158204-A1 | PHARMACOLOGICAL STIMULATION TO FACILITATE AND RESTORE STANDING AND WALKING FUNCTIONS IN SPINAL CORD MOTOR DISORDERS | ADRA2C, ADRA2A, ADRB2 | TAAR1 235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.